Captrust Financial Advisors Bio N Tech Se Transaction History

Captrust Financial Advisors

$33 Billion
Q3 2024

A detailed history of Captrust Financial Advisors transactions in Bio N Tech Se stock. As of the latest transaction made, Captrust Financial Advisors holds 3,678 shares of BNTX stock, worth $416,092. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,678

Previous 12,587 70.78%

Holding current value

$416,092

Previous $1.01 Million 56.87%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$78.36 - $124.66 $698,109 - $1.11 Million	-8,909 Reduced 70.78%	3,678 $436,000
Q2 2024 Aug 14, 2024	SELL	$80.36 - $102.87 $40,180 - $51,435	-500 Reduced 3.82%	12,587 $1.01 Million
Q1 2024 May 15, 2024	SELL	$88.96 - $112.35 $354,505 - $447,714	-3,985 Reduced 23.34%	13,087 $1.21 Million
Q4 2023 Feb 14, 2024	BUY	$90.91 - $112.75 $1.17 Million - $1.46 Million	12,907 Added 309.89%	17,072 $1.8 Million
Q3 2023 Nov 14, 2023	SELL	$98.5 - $125.08 $9,850 - $12,508	-100 Reduced 2.34%	4,165 $452,000
Q2 2023 Aug 14, 2023	BUY	$102.58 - $129.66 $17,643 - $22,301	172 Added 4.2%	4,265 $460,000
Q1 2023 May 15, 2023	BUY	$122.57 - $153.67 $612 - $768	5 Added 0.12%	4,093 $509,000
Q4 2022 Feb 15, 2023	BUY	$118.43 - $186.05 $11,132 - $17,488	94 Added 2.35%	4,088 $614,000
Q3 2022 Nov 16, 2022	BUY	$127.65 - $183.11 $373,503 - $535,779	2,926 Added 273.97%	3,994 $539,000
Q2 2022 Aug 23, 2022	SELL	$123.25 - $186.24 $49,916 - $75,427	-405 Reduced 27.49%	1,068 $159,000
Q2 2022 Aug 16, 2022	BUY	$123.25 - $186.24 $58,420 - $88,277	474 Added 47.45%	1,473 $220,000
Q1 2022 May 16, 2022	SELL	$126.25 - $231.85 $5,050 - $9,274	-40 Reduced 3.85%	999 $170,000
Q4 2021 Feb 14, 2022	BUY	$216.64 - $362.52 $12,131 - $20,301	56 Added 5.7%	1,039 $268,000
Q3 2021 Nov 16, 2021	BUY	$205.93 - $447.23 $9,472 - $20,572	46 Added 4.91%	983 $268,000
Q2 2021 Aug 16, 2021	BUY	$113.32 - $241.49 $1,133 - $2,414	10 Added 1.08%	937 $210,000
Q1 2021 May 17, 2021	BUY	$85.73 - $119.5 $45,179 - $62,976	527 Added 131.75%	927 $101,000
Q4 2020 Feb 16, 2021	BUY	$72.71 - $129.54 $23,630 - $42,100	325 Added 433.33%	400 $33,000
Q3 2020 Nov 17, 2020	BUY	$57.81 - $104.17 $4,335 - $7,812	75 New	75 $5,000

Others Institutions Holding BNTX

# of Institutions

356

Shares Held

38.3M

Call Options Held

2.45M

Put Options Held

2.29M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.5B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account

Captrust Financial Advisors Bio N Tech Se Transaction History